During the past decade, Seirei Hamamatsu General Hospital conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 7 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 5 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Seirei Hamamatsu General Hospital" #1 sponsor was "Pfizer" with 7 trials, followed by "Amgen" with 2 trials sponsored, "Associations for Establishment of Evidence in Interventions" with 2 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored and "Ferring Pharmaceuticals" with 2 trials sponsored. Other sponsors include 13 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Seirei Hamamatsu General Hospital" #1 collaborator was "Seirei Hamamatsu General Hospital" with 2 trials as a collaborator, "Alliance for Clinical Trials in Oncology" with 1 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator and "Canadian Cancer Trials Group" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Seirei Hamamatsu General Hospital" are "Rheumatoid Arthritis" (4 trials), "Coronary Artery Disease" (3 trials), "Breast Cancer" (2 trials), "Cervical Ripening" (2 trials) and "Influenza Infection" (2 trials). Many other conditions were trialed in "Seirei Hamamatsu General Hospital" in a lesser frequency.

Most popular intervention types in "Seirei Hamamatsu General Hospital" are "Drug" (25 trials), "Other" (7 trials), "Biological" (4 trials), "Device" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Baricitinib" (2 trials), "Dinoprostone" (2 trials), "Sham Procedure" (2 trials) and "cyclophosphamide" (2 trials). Other intervention names were less common.

The vast majority of trials in "Seirei Hamamatsu General Hospital" are 28 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Seirei Hamamatsu General Hospital". undefined are not yet recruiting, 5 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Seirei Hamamatsu General Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Seirei Hamamatsu General Hospital, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 5 trials that are defined as “Not Applicable".